Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants (Journal of Psychopharmacology, April 2024)
Links to other websites do not imply affiliation or endorsement. Beckley Psytech does not control and is not responsible for their content.
